Dr. Jonathan Amir Feistmann, MD

Dr. Feistmann practices at NYC Retina Surgery Center LLC in Forest Hills, New York.

Dr. Feistmann's NPI, 1447331087, was assigned on October 18, 2006. Dr. Feistmann graduated from University Of Florida College Of Medicine in 2002. Dr. Feistmann holds New York license 240088.

Dr. Feistmann's primary practice is NYC Retina Surgery Center LLC, at 107-21 Queens Blvd, Forest Hills, NY 11375 in Queens County. The practice phone is (718) 285-7585.

Dr. Feistmann's primary practice is NYC Retina Surgery Center LLC in Forest Hills, New York. Dr. Feistmann is also affiliated with New York Eye and Ear Infirmary of Mount Sinai. The medical group on file is Jamaica Hospital Medical Center. Dmand AI also links Dr. Feistmann to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feistmann practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Feistmann's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Feistmann's licenses on file in 3 states: New York, Florida and Utah.

CMS data shows 54,995 Medicare services from Dr. Feistmann across 18 procedure codes in 2024, for 722 Medicare patients. Medicare paid $2,938,469 for them. Every service was in an office.

CMS counts 722 Medicare patients who saw Dr. Feistmann in 2024. The largest group is 65 to 74, with 300 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Feistmann's median patient age at 61, with 52% women.

In 2024, Dr. Feistmann wrote 530 Medicare Part D claims for 122 patients. 61% of them were for generic drugs. CMS names the drug for 481 of them, across 11 drugs with 11 or more claims each, at $31,918 in total drug cost. In 2023, CMS named 565 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Feistmann for performance year 2024, reported as part of a group. Dr. Feistmann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of cataract surgery by Dr. Feistmann, more than 37% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Feistmann. Dr. Feistmann's most frequent co-authors are Herbert Culver Boldt, MD, Aaron Brock Roller, MD and Akbar Shakoor, MBBS.

CMS Open Payments shows 137 general payments to Dr. Feistmann from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Carl Zeiss Meditec, Inc. paid the most, $32,980.

Dr. Feistmann graduated from University Of Florida College Of Medicine in 2002.